STOCK TITAN

[Form 4] AEHR TEST SYSTEMS Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

AEHR Test Systems reported an insider transaction by its Executive VP of Sales & Marketing. On 10/27/2025, the officer had 197 shares of common stock withheld to satisfy tax obligations upon the vesting of restricted stock units, coded F at $25.14 per share. The filing notes this was a tax withholding and not a sale by the reporting person.

Following the transaction, the officer beneficially owned 178,792 shares directly. The reported total includes shares subject to unvested restricted stock units.

AEHR Test Systems ha riportato un'operazione interna da parte del suo Vicepresidente Esecutivo delle Vendite e del Marketing. Il 27/10/2025, l’ufficiale ha trattenuto 197 azioni ordinarie per soddisfare gli obblighi fiscali al vesting delle unità azionarie soggette a restrizioni, codificate F a $25,14 per azione. La dichiarazione specifica che si è trattato di una ritenuta fiscale e non di una vendita da parte della persona riportante.

Dopo l'operazione, l’ufficiale deteneva beneficiariamente 178.792 azioni direttamente. Il totale riportato include azioni soggette a restrizioni non vestite.

AEHR Test Systems informó una operación interna por su Vicepresidente Ejecutivo de Ventas y Marketing. El 27/10/2025, el directivo tuvo retenidas 197 acciones comunes para satisfacer las obligaciones fiscales al vesting de unidades de acciones restringidas, codificadas como F a $25.14 por acción. El archivo indica que se trató de una retención fiscal y no de una venta por la persona que reporta.

Tras la operación, el directivo poseía beneficiosamente directamente 178,792 acciones. El total reportado incluye acciones sujetas a unidades de acciones restringidas no vestidas.

AEHR Test Systems는 영업마케팅 부문 수석 부사장의 내부자 거래를 보고했습니다. 2025년 10월 27일, 해당 임원은 제한 주식단위의 권리 행사에 따른 세금 의무를 충당하기 위해 197주의 보통주를 원천징수로 보유했으며, 주당 가격은 $25.14F로 표시되었습니다. 제출 문서에는 이것이 세금 원천징수였으며 보고자의 매도가 아님이 명시되어 있습니다.

거래 후 임원은 직접적으로 178,792주를 유익하게 소유하고 있습니다. 보고된 총액에는 미 vest된 제한 주식단위의 주식이 포함되어 있습니다.

AEHR Test Systems a été révélée une transaction d’initiée par son Vice-éxécutif des Ventes et du Marketing. Le 27/10/2025, le cadre a retenu 197 actions ordinaires pour satisfaire les obligations fiscales liées à la levée des unités d’actions restreintes, codées F à $25,14 par action. Le dépôt précise qu’il s’agit d’une retenue fiscale et non d’une vente par la personne déclarant.

Suite à l’opération, le cadre détenait directement 178 792 actions en propriété bénéficiaire. Le total déclaré inclut des actions soumises à des unités d’actions restreintes non acquises.

AEHR Test Systems meldete eine Insider-Transaktion durch seinen Executive Vice President of Sales & Marketing. Am 27.10.2025 hielt der Beauftragte 197 Aktien Stammaktien ein, um steuerliche Verpflichtungen bei der Vesting von Restricted Stock Units zu erfüllen, kodiert F bei $25,14 pro Aktie. Die Einreichung vermerkt, dass dies eine Steuerabzug war und kein Verkauf durch die meldende Person.

Nach der Transaktion hielt der Beauftragte direkt 178.792 Aktien vorteilhaft. Die gemeldete Gesamtzahl umfasst Aktien, die Restricted Stock Units unterliegen, die noch nicht vestet sind.

AEHR Test Systems أبلغت عن صفقة داخلية من قبل نائب رئيسها التنفيذي للمبيعات والتسويق. في 27/10/2025، احتفظ المسؤول بـ 197 سهماً من الأسهم العادية لتلبية الالتزامات الضريبية عند vesting وحدات الأسهم المقيدة، مُرمَّزة بـ F عند $25.14 للسهم. تشير الإيداع إلى أن هذا كان حجزاً ضريبياً وليس بيعاً من قبل الشخص المبلغ عنه.

بعد المعاملة، أصبح يمتلك المسؤول بشكل مباشر 178,792 سهماً مفيداً. الإجمالي المُبلغ عنه يشمل الأسهم الخاضعة للوحدات المقيدة التي لم تتجرد vest.

Positive
  • None.
Negative
  • None.

AEHR Test Systems ha riportato un'operazione interna da parte del suo Vicepresidente Esecutivo delle Vendite e del Marketing. Il 27/10/2025, l’ufficiale ha trattenuto 197 azioni ordinarie per soddisfare gli obblighi fiscali al vesting delle unità azionarie soggette a restrizioni, codificate F a $25,14 per azione. La dichiarazione specifica che si è trattato di una ritenuta fiscale e non di una vendita da parte della persona riportante.

Dopo l'operazione, l’ufficiale deteneva beneficiariamente 178.792 azioni direttamente. Il totale riportato include azioni soggette a restrizioni non vestite.

AEHR Test Systems informó una operación interna por su Vicepresidente Ejecutivo de Ventas y Marketing. El 27/10/2025, el directivo tuvo retenidas 197 acciones comunes para satisfacer las obligaciones fiscales al vesting de unidades de acciones restringidas, codificadas como F a $25.14 por acción. El archivo indica que se trató de una retención fiscal y no de una venta por la persona que reporta.

Tras la operación, el directivo poseía beneficiosamente directamente 178,792 acciones. El total reportado incluye acciones sujetas a unidades de acciones restringidas no vestidas.

AEHR Test Systems는 영업마케팅 부문 수석 부사장의 내부자 거래를 보고했습니다. 2025년 10월 27일, 해당 임원은 제한 주식단위의 권리 행사에 따른 세금 의무를 충당하기 위해 197주의 보통주를 원천징수로 보유했으며, 주당 가격은 $25.14F로 표시되었습니다. 제출 문서에는 이것이 세금 원천징수였으며 보고자의 매도가 아님이 명시되어 있습니다.

거래 후 임원은 직접적으로 178,792주를 유익하게 소유하고 있습니다. 보고된 총액에는 미 vest된 제한 주식단위의 주식이 포함되어 있습니다.

AEHR Test Systems a été révélée une transaction d’initiée par son Vice-éxécutif des Ventes et du Marketing. Le 27/10/2025, le cadre a retenu 197 actions ordinaires pour satisfaire les obligations fiscales liées à la levée des unités d’actions restreintes, codées F à $25,14 par action. Le dépôt précise qu’il s’agit d’une retenue fiscale et non d’une vente par la personne déclarant.

Suite à l’opération, le cadre détenait directement 178 792 actions en propriété bénéficiaire. Le total déclaré inclut des actions soumises à des unités d’actions restreintes non acquises.

AEHR Test Systems meldete eine Insider-Transaktion durch seinen Executive Vice President of Sales & Marketing. Am 27.10.2025 hielt der Beauftragte 197 Aktien Stammaktien ein, um steuerliche Verpflichtungen bei der Vesting von Restricted Stock Units zu erfüllen, kodiert F bei $25,14 pro Aktie. Die Einreichung vermerkt, dass dies eine Steuerabzug war und kein Verkauf durch die meldende Person.

Nach der Transaktion hielt der Beauftragte direkt 178.792 Aktien vorteilhaft. Die gemeldete Gesamtzahl umfasst Aktien, die Restricted Stock Units unterliegen, die noch nicht vestet sind.

AEHR Test Systems أبلغت عن صفقة داخلية من قبل نائب رئيسها التنفيذي للمبيعات والتسويق. في 27/10/2025، احتفظ المسؤول بـ 197 سهماً من الأسهم العادية لتلبية الالتزامات الضريبية عند vesting وحدات الأسهم المقيدة، مُرمَّزة بـ F عند $25.14 للسهم. تشير الإيداع إلى أن هذا كان حجزاً ضريبياً وليس بيعاً من قبل الشخص المبلغ عنه.

بعد المعاملة، أصبح يمتلك المسؤول بشكل مباشر 178,792 سهماً مفيداً. الإجمالي المُبلغ عنه يشمل الأسهم الخاضعة للوحدات المقيدة التي لم تتجرد vest.

AEHR Test Systems 报告了其销售与市场执行副总裁的内幕交易。2025年10月27日,该官员以扣留方式保留了197股普通股,以满足受限股票单位归属时的税务义务,代码为F,每股价格为$25.14。申报指出这是税收代扣,而不是该报告人的出售。

交易之后,该官员直接持有178,792股受益所有权。所报告的总数包括尚未归属的受限股票单位所涉及的股票。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ROGERS VERNON

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec VP of Sales & Mktg.
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 F 197(1) D $25.14 178,792(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
2. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/Chris Siu, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AEHR (AEHR) disclose in this Form 4?

An officer reported a tax withholding transaction related to RSU vesting, with 197 shares withheld at $25.14 on 10/27/2025.

Who is the insider in AEHR’s Form 4?

The reporting person is AEHR’s Executive VP of Sales & Marketing.

How many shares were involved and at what price?

197 shares were withheld for taxes at a price of $25.14 per share.

Was this a sale of AEHR shares by the insider?

No. The filing states the shares were withheld to satisfy tax withholding upon RSU vesting and do not represent a sale.

How many AEHR shares does the insider own after the transaction?

Beneficial ownership is 178,792 shares held directly, which includes shares subject to unvested RSUs.

Were any derivative securities reported?

No derivative securities were listed in the transaction table.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

752.87M
28.10M
5.31%
60.66%
18.86%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT